Netflix Shares Drop After Earnings, and the Top Biotech Analyst Dissects the Race for a COVID Cure

Netflix Shares Drop After Earnings, and the T...

Up next

Strong Memory Momentum… And The Next Move For Retail Stocks 3/17/26

Storage stocks rallying to record highs, as demand for AI memory continues to climb. How much farther the group has to run, and what Nvidia CEO Jensen Huang said about the next evolution in the space. Plus The numbers out of Lululemon’s latest quarter, and where a top retail anal ...  Show more

Nvidia’s GTC Conference Underway… And When To Buy The Dip 3/16/26

All eyes on Nvidia, as the chip giant kicks off its GTC conference. The next-gen GPU’s investors are waiting to hear about, and what it means for the stock’s next move. Plus Stocks rallying to start the week, as oil pulls back on the latest developments out of Iran. What a top ma ...  Show more

Recommended Episodes

Stocks Erase Losses from Monday's Sell-off, Dow Components Join the Earnings Parade, Netflix's Subscriber Growth Slowdown, United Sees Profitablilty Ahead, J&J's COVID Vaccine Under Scrutiny, and Chipotle's Results Heat Up the Stock
Squawk on the Street

Jim Cramer and David Faber took an in-depth look at a busy day for the markets with a slew of earnings reports in the mix -- as stocks recouped all of their losses from Monday's sell-off. Dow components Coca-Cola, Johnson & Johnson and Verizon all beating analyst expectations wit ...  Show more

Pharma raises its bet on biotech
Behind the Money

In the past month pharmaceutical companies have spent almost $100bn acquiring biotech companies. The FT's Sarah Neville explains why big pharma is raising its bet on the drug pipelines owned by biotechs, and why analysts expect more consolidation in 2019. 


Read ...

  Show more

Pfizer & BioNTech Share Results on Boosters as Job Openings Near All-Time High
Real Vision: Finance & Investing

DB-Dec08,2021:With markets easing on Omicron fears this week and assets across the board beginning to recover from last week’s drawdowns, Pfizer and BioNTech both announced today the initial findings of the effectiveness of their boosters against the Omicron variant, demonstratin ...  Show more

Upstart CEO, Biohaven Pharma CEO, Crocs CEO & Sysco CEO 5/10/22
Mad Money w/ Jim Cramer

The Dow continued to move lower while the S&P 500 and Nasdaq rose, and Jim Cramer is taking you through the day’s action. Then, after Upstart fell 56% today and CEO Dave Girouard sits down to break down yesterday's earnings and find out what sent the stock tumbling. And, Pfizer a ...  Show more